305 related articles for article (PubMed ID: 15592454)
1. Substrate recognition strategy for botulinum neurotoxin serotype A.
Breidenbach MA; Brunger AT
Nature; 2004 Dec; 432(7019):925-9. PubMed ID: 15592454
[TBL] [Abstract][Full Text] [Related]
2. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
3. Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex.
Silvaggi NR; Wilson D; Tzipori S; Allen KN
Biochemistry; 2008 May; 47(21):5736-45. PubMed ID: 18457419
[TBL] [Abstract][Full Text] [Related]
4. 2.3 A crystal structure of tetanus neurotoxin light chain.
Breidenbach MA; Brunger AT
Biochemistry; 2005 May; 44(20):7450-7. PubMed ID: 15895988
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
Agarwal R; Binz T; Swaminathan S
Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
8. Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate.
Fu Z; Chen S; Baldwin MR; Boldt GE; Crawford A; Janda KD; Barbieri JT; Kim JJ
Biochemistry; 2006 Jul; 45(29):8903-11. PubMed ID: 16846233
[TBL] [Abstract][Full Text] [Related]
9. Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide libraries.
Hayden J; Pires J; Roy S; Hamilton M; Moore GJ
J Appl Toxicol; 2003; 23(1):1-7. PubMed ID: 12518330
[TBL] [Abstract][Full Text] [Related]
10. Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation.
Ibañez C; Blanes-Mira C; Fernández-Ballester G; Planells-Cases R; Ferrer-Montiel A
FEBS Lett; 2004 Dec; 578(1-2):121-7. PubMed ID: 15581628
[TBL] [Abstract][Full Text] [Related]
11. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.
Arndt JW; Jacobson MJ; Abola EE; Forsyth CM; Tepp WH; Marks JD; Johnson EA; Stevens RC
J Mol Biol; 2006 Sep; 362(4):733-42. PubMed ID: 16938310
[TBL] [Abstract][Full Text] [Related]
12. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
[TBL] [Abstract][Full Text] [Related]
13. The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability.
Baldwin MR; Bradshaw M; Johnson EA; Barbieri JT
Protein Expr Purif; 2004 Sep; 37(1):187-95. PubMed ID: 15294297
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.
Segelke B; Knapp M; Kadkhodayan S; Balhorn R; Rupp B
Proc Natl Acad Sci U S A; 2004 May; 101(18):6888-93. PubMed ID: 15107500
[TBL] [Abstract][Full Text] [Related]
15. Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2.
Yamasaki S; Binz T; Hayashi T; Szabo E; Yamasaki N; Eklund M; Jahn R; Niemann H
Biochem Biophys Res Commun; 1994 Apr; 200(2):829-35. PubMed ID: 7910017
[TBL] [Abstract][Full Text] [Related]
16. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
Hanson MA; Stevens RC
Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the protease from Clostridium botulinum serotype C responsible for nicking in botulinum neurotoxin complex.
Suzuki T; Yoneyama T; Miyata K; Mikami A; Chikai T; Inui K; Kouguchi H; Niwa K; Watanabe T; Miyazaki S; Ohyama T
Biochem Biophys Res Commun; 2009 Feb; 379(2):309-13. PubMed ID: 19103155
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A.
Masuyer G; Thiyagarajan N; James PL; Marks PM; Chaddock JA; Acharya KR
Biochem Biophys Res Commun; 2009 Mar; 381(1):50-3. PubMed ID: 19351593
[TBL] [Abstract][Full Text] [Related]
19. New insights into clostridial neurotoxin-SNARE interactions.
Breidenbach MA; Brunger AT
Trends Mol Med; 2005 Aug; 11(8):377-81. PubMed ID: 16006188
[TBL] [Abstract][Full Text] [Related]
20. Bis-imidazoles as molecular probes for peripheral sites of the zinc endopeptidase of botulinum neurotoxin serotype A.
Merino I; Thompson JD; Millard CB; Schmidt JJ; Pang YP
Bioorg Med Chem; 2006 May; 14(10):3583-91. PubMed ID: 16458011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
